Product Information
To improve the quality and the yield of monoclonal antibody production, ZXBio develops novel cell culturing technologies. All the monoclonal antibody products are produced using hybridomas or CHO cell lines under serum-free culturing conditions. ZXBio's optimized method (Patent Number: cn 201811187760.2) is superior to traditional ascites production method, which always contaminates the purified antibodies with host proteins. Using affinity purification, ZXBio is able to purify monoclonal antibodies at a purity higher than 95% for research and in vitro diagnostic purposes.
ZXBio develops fluorescent labeling techniques in-house (Patent Number: cn 202010087828.0), all its fluorescent labeling antibodies are manufactured according to the highest industry standard (Pharmaceutical industry standard of the People's Republic of China, YY/T 1184-2010).
Product Category
- Antibodies: research antibodies, diagnostic antibodies, antibody drugs
- Bioreagents: Labeling Probes (protein and iFluor dyes); Crosslinkers; synthesized peptide probe
Diagnostic Antibody Manufacture
- Gram level antibody production
- Antibody purity > 95%
- BCA assay determination of antibody concentration
- Antibody valence determination
- Low endotoxin level (<2EU/mg)
- Following medical device GMP standard
- Provide documents which helps trace to the source
Research-Usage Antibody Manufacture
- Gram level antibody production
- Antibody purity > 95%
- BCA assay determination of antibody concentration
- Antibody valence determination
- Low endotoxin level (<2EU/mg)